Right-To-Try Bill Heads To White House, Putting Firms In Driver's Seat

Proponent says companies ready to use new expanded access pathway that US FDA will have essentially no involvement in.

Capitol House

Drug companies apparently already are lining up to use the new pathway established by right to try legislation that is expected to be enacted within days.

The House of Representatives on May 22 voted 250 to 169 to send the Trickett Wendler, Frank Mongiello, Jordan...

More from Legislation

More from Pink Sheet